Security Snapshot

Merck & Co Inc - COM Institutional Ownership

CUSIP: 589331107

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

5

Shares (Excl. Options)

383,094

Price

$120.29

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 4 signals
Portfolio coverage rank
0%
Share change
-2,100
Value change
-$252,613
Number of holders
5
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$120.29
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • 589331107 - Merck & Co Inc - COM is tracked under CUSIP 589331107.
  • 5 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 5 to 5 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $40,545,499 to $46,082,356.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 5 institutions filings for Q1 2026.

Open SEC evidence

Security key

589331107

Latest holder period

Q1 2026

13F holders

5

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 5 institutional investors reported holding 383,094 shares of Merck & Co Inc - COM.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 383,094 $46,082,356 -$252,613 $120.29 5
2025 Q4 385,194 $40,545,499 -$635,144 $105.26 5
2025 Q3 416,237 $32,884,627 -$1,466,748 $83.93 7
2025 Q2 537,423 $40,551,450 -$1,665,359 $79.16 8
2025 Q1 553,221 $47,865,884 -$3,838,658 $89.76 7
2024 Q4 593,189 $57,031,746 -$2,216,000 $99.48 11
2024 Q3 615,024 $67,618,159 -$984,622 $113.56 12
2024 Q2 623,330 $77,168,463 +$267,290 $123.80 12
2024 Q1 619,084 $81,688,280 -$99,593 $131.95 10
2023 Q4 621,925 $67,987,260 -$159,223 $109.02 11
2023 Q3 623,284 $64,167,257 -$8,487,847 $102.95 9
2023 Q2 705,730 $81,434,640 -$336,134 $115.39 9
2023 Q1 708,643 $75,392,319 -$626,254 $106.39 9
2022 Q4 748,631 $83,060,022 -$3,174,604 $110.95 11
2022 Q3 778,898 $67,078,968 -$3,264,022 $86.12 11
2022 Q2 814,768 $74,280,990 +$132,990 $91.17 12
2022 Q1 813,740 $66,751,973 -$51,383,404 $82.05 13
2021 Q4 1,486,743 $113,942,476 -$1,874,337 $76.64 14
2021 Q3 1,511,209 $113,505,927 -$4,600,689 $75.11 15
2021 Q2 1,571,594 $122,219,665 -$7,025,472 $77.77 16
2021 Q1 1,662,875 $128,192,016 -$4,111,510 $77.09 17
2020 Q4 1,716,189 $140,384,569 -$8,311,375 $81.80 17
2020 Q3 1,817,281 $150,744,003 -$9,602,504 $82.95 19
2020 Q2 1,933,042 $149,481,048 -$9,002,258 $77.33 19
2020 Q1 2,049,596 $155,410,582 +$1,126,737 $76.94 21
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .